Orexigen Therapeutics, Inc. Insider Trading for July 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Orexigen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Orexigen Therapeutics, Inc. for July 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Lynch Thomas P. | EVP. General Counse ... | Option Exercise | A | 15.00 | 15,750 | 236,250 | 15,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Lynch Thomas P. | EVP. General Counse ... | Option Exercise | A | 15.00 | 78,750 | 1,181,250 | 78,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Lynch Thomas P. | EVP. General Counse ... | Option Exercise | A | 4.02 | 26,250 | 105,525 | 26,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Lynch Thomas P. | EVP. General Counse ... | Option Exercise | A | 4.02 | 131,250 | 527,625 | 131,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 15,750 | 236,250 | 15,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 78,750 | 1,181,250 | 78,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 26,250 | 105,525 | 26,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Keyes Jason A | SVP, Chief Financia ... | Option Exercise | A | 4.02 | 131,250 | 527,625 | 131,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Flynn Peter D | SVP, Dev, Reg Affa ... | Option Exercise | A | 15.00 | 15,750 | 236,250 | 15,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Flynn Peter D | SVP, Dev, Reg Affa ... | Option Exercise | A | 15.00 | 78,750 | 1,181,250 | 78,750 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Flynn Peter D | SVP, Dev, Reg Affa ... | Option Exercise | A | 4.02 | 26,250 | 105,525 | 26,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Flynn Peter D | SVP, Dev, Reg Affa ... | Option Exercise | A | 4.02 | 131,250 | 527,625 | 131,250 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 15.00 | 31,500 | 472,500 | 31,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 15.00 | 157,500 | 2,362,500 | 157,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 4.02 | 52,500 | 211,050 | 52,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Cannell Thomas R | EVP, Chief Commerci ... | Option Exercise | A | 4.02 | 262,500 | 1,055,250 | 262,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 15.00 | 63,000 | 945,000 | 63,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 15.00 | 315,000 | 4,725,000 | 315,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 4.02 | 105,000 | 422,100 | 105,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | NARACHI MICHAEL | CEO & President | Option Exercise | A | 4.02 | 525,000 | 2,110,500 | 525,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | DOVEY BRIAN H | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Moglia Stephen A. | VP, Chief Accountin ... | Option Exercise | A | 15.00 | 28,800 | 432,000 | 28,800 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Moglia Stephen A. | VP, Chief Accountin ... | Option Exercise | A | 4.02 | 48,000 | 192,960 | 48,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Zoth Lota S. | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | JORN DEBORA | Director | Option Exercise | A | 4.02 | 16,500 | 66,330 | 16,500 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Honig Peter | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | Endicott David J. | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 | |
| Jul 14 2016 | OREX | Orexigen Therapeut ... | BOCK LOUIS C | Director | Option Exercise | A | 4.02 | 15,000 | 60,300 | 15,000 |